Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02241252 · ClinicalTrials.gov registry record · NA
Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02241252 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 29 participants.
The verdict
NCT02241252, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study will validate the recording accuracy of a specific electrical interval of the heart, the QT interval, between an iPhone rhythm strip recording and a traditional 12-lead electrocardiogram (ECG). These measurements will occur in hospitalized patients that are starting either sotalol or dofetilide, since both of these medications can prolong the QT interval.
Interventions
- DEVICE iPhone ECG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02241252
The ClinicalTrials.gov registry entry for NCT02241252 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iPhone ECG is the first listed.
NCT02241252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02241252 about?
NCT02241252 is a clinical study titled "Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients". This study will validate the recording accuracy of a specific electrical interval of the heart, the QT interval, between an iPhone rhythm strip recording and a traditional 12-lead electrocardiogram (ECG). These measurements will occur in hospitalized patients that are starting either sotalol or dofe...
What is the current status of trial NCT02241252?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2013-09. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02241252?
The interventions under investigation include: iPhone ECG (DEVICE).
Who is sponsoring clinical trial NCT02241252?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.